SPIRONOLACTONE
HETERO LABS LTD III · SPIRONOLACTONE
Open FDA's page for this record- Application number
- ANDA218085
- Sponsor name
- HETERO LABS LTD III
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250221
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- SPIRONOLACTONE
- Reference standard
- No
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- SPIRONOLACTONE
- Strength
- 25MG/5ML
- Harmonized identifiers (openFDA)
- Application number
- ANDA218085
- Brand name
- SPIRONOLACTONE
- Generic name
- SPIRONOLACTONE
- Manufacturer name
- Camber Pharmaceuticals, Inc.
- Product NDC
- 31722-691
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- SPIRONOLACTONE
- RxCUI
- 104232
- SPL ID
- 3241a29b-82b9-fd3a-e063-6294a90aa46c
- SPL set ID
- 4ac2926a-949a-4383-b0b0-92c0822dfcda
- Package NDC
- 31722-691-11, 31722-691-47
- Nui
- N0000175557, N0000011310
- Pharm class epc
- Aldosterone Antagonist [EPC]
- Pharm class moa
- Aldosterone Antagonists [MoA]
- UNII
- 27O7W4T232
